Siller v. Janssen Research & Development LLC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Siller v. Janssen Research & Development LLC

Sort by

Viewing results 1‒6 of 6

Equities
Markets Now - Monday 13th July 2020
...Causeway Capital Management LLC, the LA hedge fund, has declared 4.88 per cent of Micro Focus....
July 13, 2020
The Big ReadSarah Neville
Big pharma takes a gamble on NHS experiment
...But a more precise understanding of biology has led pharmaceutical companies to focus research and development efforts on treatments for rarer diseases, often aimed at small sub groups with a particular...
August 28, 2018
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Technology sector
Chinese start-up under fire for using Google Chrome files
...Mr You said the issue at Redcore highlighted how China remained far behind its western peers in terms of technological know-how and development....
August 16, 2018
UK companies
AstraZeneca faces calls for shake-up
...You either need Attila the Hun – a total butcher – to run it down until it can be bought, or a Paul Janssen-like figure: a successful scientist who can really take on the research team.”...
April 9, 2012
FT AlphavillePrivate equity
Indie v sell-side research and a UniCredit spam alert
...Today, information control has become the hot button topic leading clients to focus on research providers’ compliance controls and practices – a development that benefits sell-side research firms....
November 16, 2011
Climate change
Foreign groups circle power-hungry India
...That restriction, says V....
January 15, 2009
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference

Previous pagePage 1 of 1Next page